COVID-19 vaccine acceptance among haemodialysis patients: a French survey.
COVID-19 vaccine acceptance among haemodialysis patients: a French survey.
复制标题
DOI:
10.1093/ckj/sfab084
复制
发表时间:
2021-08
影响因子:
4.6
通讯作者:
Chalencon E
中科院分区:
文献类型:
--
作者:
Andrian T;Koppe L;Novel E;Massat M;Barba C;Ioriatti D;Barnel C;Villar E;Luce M;Guerraoui A;Mezaache S;Kalbacher E;Tournebize C;Fouque D;Chalencon E
Compelling evidence has shown that chronic kidney disease (CKD) is not only the most prevalent comorbidity associated with severe coronavirus disease 2019 (COVID-19), but also a condition that conveys the highest risk of death among infected patients [1]. Urgent calls have been made by leading working groups in order to grant these patients priority access to vaccination [2, 3]. French health authorities implemented a priority vaccine program for haemodialysis patients [4], leaving only one major barrier for successful mass vaccination: vaccine hesitancy. Here we report COVID-19 vaccine acceptance from six maintenance haemodialysis centres located in Lyon, France. Our study consisted of a paper survey distributed to all patients during their haemodialysis session. Participants were asked whether they were in favour of COVID-19 vaccine (including whether they were already vaccinated or willing to be) or against it. In case of refusal, further questions aimed to assess possible reasons. Further information was collected using scale-type answers for patients to self-estimate their health status and risk of being infected. Vaccine hesitancy was evaluated according to the World Health Organization definition [5, 6] as a positive answer to at least one of the following questions:(i) Have you ever refused a vaccine for yourself or a child because you considered it as useless or dangerous?(ii)Have you ever postponed a vaccine recommended by a physician because of doubts about it? and (iii) Have you ever had a vaccine for a child or yourself despite doubts about its efficacy? Patients were asked if they received influenza vaccination in the early winter of 2020.
影响因子:
5.5
作者:
Larson, Heidi J.;Jarrett, Caitlin;Wilson, Rose
通讯作者:
Wilson, Rose
DOI:
10.1093/ndt/gfaa314
发表时间:
2021-01-01
期刊:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
影响因子:
--
作者:
ERA-EDTA Council;ERACODA Working Group
通讯作者:
ERACODA Working Group
影响因子:
5.5
作者:
MacDonald, Noni E.
通讯作者:
MacDonald, Noni E.